Monte Rosa Therapeutics, Inc. (GLUE)

Typically moves ±6.26% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-07 ESTIMATED

Across 20 earnings reports since Aug 12, 2021, Monte Rosa Therapeutics, Inc. (GLUE) has a clear post-earnings pattern. It moves ±6.26% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +16.33% (Mar 29, 2022) and its largest decline was -16.03% (May 11, 2022). The next earnings report is predicted for 2026-08-07 (estimated).

Earnings reactions

How GLUE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.26%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☀ PRE	-2.73%	open_in_new
Mar 17, 2026	☀ PRE	-1.96%	open_in_new
Nov 06, 2025	☀ PRE	+5.69%	open_in_new
Aug 07, 2025	☀ PRE	-2.87%	open_in_new
May 08, 2025	☀ PRE	+9.61%	open_in_new
Mar 20, 2025	☀ PRE	+5.37%	open_in_new
Nov 07, 2024	☀ PRE	+0.85%	open_in_new
Aug 08, 2024	☀ PRE	+10.25%	open_in_new
May 09, 2024	☀ PRE	-1.52%	open_in_new
Mar 14, 2024	☀ PRE	-8.42%	open_in_new
Nov 09, 2023	☀ PRE	-10.57%	open_in_new
Aug 10, 2023	☀ PRE	-1.62%	open_in_new
May 11, 2023	☀ PRE	+1.04%	open_in_new
Mar 16, 2023	☀ PRE	+7.35%	open_in_new
Nov 10, 2022	☀ PRE	+5.26%	open_in_new
Aug 11, 2022	☀ PRE	+5.17%	open_in_new
May 11, 2022	☀ PRE	-16.03%	open_in_new
Mar 29, 2022	☀ PRE	+16.33%	open_in_new
Nov 12, 2021	☽ POST	-8.69%	open_in_new
Aug 12, 2021	☀ PRE	-3.88%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.26%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 20 →

Funds holding

$227581378

Total value held

Buying

16 added · 3 reduced

Blackrock, Inc.

$92739901 +34.84%

State Street Corp

$55172971 +59.15%

Goldman Sachs Group Inc

$16475119 +238.49%

Northern Trust Corp

$13597964 +18.59%

Janus Henderson Group Plc

$11293772 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260717	open_in_new SEC.gov
144	20260716	open_in_new SEC.gov
4	20260716	open_in_new SEC.gov
144	20260715	open_in_new SEC.gov
SCHEDULE 13G/A	20260708	open_in_new SEC.gov
4	20260707	open_in_new SEC.gov
4	20260706	open_in_new SEC.gov
SCHEDULE 13D/A	20260706	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
144	20260630	open_in_new SEC.gov

Frequently asked about GLUE earnings

When does Monte Rosa Therapeutics, Inc. report earnings next? expand_more

Monte Rosa Therapeutics, Inc. (GLUE)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GLUE stock move after earnings? expand_more

Over 20 reports, GLUE has moved an average of ±6.26% the session after earnings, closing higher 50.0% of the time.

What was GLUE's biggest post-earnings move? expand_more

GLUE's largest post-earnings gain on record was +16.33% on Mar 29, 2022, and its largest decline was -16.03% on May 11, 2022.

Where can I find Monte Rosa Therapeutics, Inc.'s SEC filings? expand_more

All of Monte Rosa Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.